Investment firm outlines venture model built on autonomy and platform support

An investment firm says its roots lie in growth capital as well as private equity, citing an early investment in Staples when the company had about five stores. It says venture investing differs from buyouts because decisions are made with limited or almost no historical information, placing more emphasis on talent and a team’s ability to adapt as technology changes.

The firm uses separate investment committees and processes for different segments. Its life sciences business relies on MD-PhDs to assess compounds and clinical probabilities, rather than applying a centralized approach across all investments.

The firm says its broader platform can connect venture companies with major global customers, pharmaceutical companies, potential buyers and partners, and capital markets. It views the model as powerful when specialized teams retain enough autonomy and trust to operate independently while using shared platform resources; it also predicts venture businesses will need capital or eventually access public markets.